Susceptibility of Streptococcus pyogenes from throat cultures to macrolide antibiotics and influence of collection criteria

Clinical Microbiology and Infection

Volumn 3, Issue 1, 1997, Pages 58-62

  Giovanetti, Eleonora ^a   Prenna, Manuela ^b   Repetto, Antonella ^c   Biavasco, Francesca ^a   Romagnoli, Mario ^c   Ripa, Sandra ^b   Varaldo, Pietro E ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c Monteluce Hospital   (Italy)

Author keywords

Erythromycin resistance; Macrolide antibiotics; Streptococcus pyogenes

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRICS; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; THROAT CULTURE; TONSILLITIS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES; TRIXIS;

EID: 0030997174     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00252.x     Document Type: Article

References (27)

1. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325: 783-93.
2. Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10: 55-7.
3. van Asselt GJ, Mouton RP, van Boven CPA. Penicillin tolerance and treatment failure in group A streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis 1996; 15: 107-15.
4. Brook I The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601-7.
5. Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis 1992; 14(Suppl. 2): S218-23.
6. Moellering RC Jr. Revolutionary changes in the macrolide and azalide antibiotics. Am J Med 1991; 91(Suppl, 1): S1-4.
7. Lowbury EJL, Hurst L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J Clin Pathol 1959; 12: 163-9.
8. Dixon JMS, Lipinski E. Occurrence of antibiotic resistance in hemolytic streptococci. In Schlessinger D, ed. Microbiology - 1982. Washington: American Society for Microbiology, 1982: 147-50.
9. Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985; 16(Suppl. A): S137-49.
10. Nakae M, Murai T, Kaneko Y, Mitsuhashi S. Drug resistance in Streptococcus pyogenes isolated in Japan (1974-1975). Antimicrob Agents Chemother 1977; 12: 427-8.
11. Miyamoto Y, Takizawa K, Matsushima A, Asai Y, Nakatsuka S. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Antimicrob Agents Chemother 1978; 13: 399-404.
12. Maruyama S, Yoshioka H, Fujita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics. Am J Dis Child 1979; 133: 1143-5.
13. Mitsuhashi S, Inoue M, Saito K, Nakae M. Drug resistance in Streptococcus pyogenes strains isolated in Japan. In Schlessinger D, ed. Microbiology - 1982. Washington: American Society for Microbiology, 1982: 151-4.
14. Spencer RC, Wheat PF, Magee JT, Brown EH. Erythromycin resistance in streptococci [letter]. Lancet 1989; i: 168.
15. Wittier RR, Yamada SM, Bass JW, Hamill R, Wiebe RA, Ascher DP. Penicillin tolerance and erythromycin resistance of group A β-hemolytic streptococci in Hawaii and the Philippines. Am J Dis Child 1990; 144: 587-9.
16. Betriu C, Sanchez A, Gomez M, Cruceyra A, Picazo JJ. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother 1993; 37: 1717-19.
17. van Asselt GJ, Sloos JH, Mouton RP, van Boven CPA, van de Klundert JAM. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin. J Med Microbiol 1995; 43: 386-91.
18. Zackrisson G, Lindt L, Roos K, Larsson P. Erythromycinresistant beta-hemolytic streptococci group A in Göteborg, Sweden. Scand J Infect Dis 1988; 20: 419-20.
19. Stingemore N, Francis GR, Toohey M, McGechie B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust 1989; 150: 626-31.
20. Phillips G, Parratt D, Orange Gy Harper I, McEwan H, Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother 1990; 25: 723-4.
21. Seppälä H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 292-7.
22. Hsueh PR, Chen HM, Huang AH, Wu JJ. Erythromycin-resistant Streptococcus pyogenes in Taiwan [abstract E54]. In: Program and Abstracts of the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington, DC: American Society for Microbiology, 1995: 95.
23. Cornaglia G, Lissandrini D, Valentini M, Fontana R. Inusuale incidenza di resistenza ai macrolidi in isolati clinici di Streptococcus pyogenes [abstract]. In: Programma e riassunti del 25° Congresso Nazionale della Società Italiana di Microbiologia, Alghero, Italy. SIM, 1995: 337.
24. Cipriani P, Debbia EA, Gesu GP, et al. Indagine policentrica AMCLI sull'incidenza di resistenze agli antibiotici in S. pyogenes [abstract G122]. In: Programma e riassunti del XXIV Congresso Nazionale dell'Associazione Italiana Microbiologi Clinici, Riva del Garda, Italy. AMCLI, 1995: 182.
25. Tempera G, Furneri PM, Nicolosi VM, Nicoletti G. In vitro activity of some macrolides against S. pyogenes [abstract 3.12]. In: Program and Abstracts of the 3rd International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, Portugal. 1996: 30.
26. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. Approved standard M7-A3. Villanova, PA: NCCLS, 1993.
27. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. Villanova, PA: NCCLS, 1995.